Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus.

Doss M, Ruchala P, Tecle T, Gantz D, Verma A, Hartshorn A, Crouch EC, Luong H, Micewicz ED, Lehrer RI, Hartshorn KL.

J Immunol. 2012 Mar 15;188(6):2759-68. doi: 10.4049/jimmunol.1101335. Epub 2012 Feb 15.

2.

Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D.

Doss M, White MR, Tecle T, Gantz D, Crouch EC, Jung G, Ruchala P, Waring AJ, Lehrer RI, Hartshorn KL.

J Immunol. 2009 Jun 15;182(12):7878-87. doi: 10.4049/jimmunol.0804049.

3.
4.

The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.

Tripathi S, Tecle T, Verma A, Crouch E, White M, Hartshorn KL.

J Gen Virol. 2013 Jan;94(Pt 1):40-9. doi: 10.1099/vir.0.045013-0. Epub 2012 Oct 10.

5.

Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.

Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.

J Virol. 2004 May;78(10):5147-56.

6.

Retrocyclins: using past as prologue.

Cole AM, Wang W, Waring AJ, Lehrer RI.

Curr Protein Pept Sci. 2004 Oct;5(5):373-81. Review.

PMID:
15544532
7.

Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes.

White MR, Kandel R, Tripathi S, Condon D, Qi L, Taubenberger J, Hartshorn KL.

PLoS One. 2014 Jul 2;9(7):e101364. doi: 10.1371/journal.pone.0101364. eCollection 2014.

8.

Activity of alpha- and theta-defensins against primary isolates of HIV-1.

Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI.

J Immunol. 2004 Jul 1;173(1):515-20.

9.

Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.

Wang W, Mulakala C, Ward SC, Jung G, Luong H, Pham D, Waring AJ, Kaznessis Y, Lu W, Bradley KA, Lehrer RI.

J Biol Chem. 2006 Oct 27;281(43):32755-64. Epub 2006 Jun 21.

10.

Multiple components contribute to ability of saliva to inhibit influenza viruses.

White MR, Helmerhorst EJ, Ligtenberg A, Karpel M, Tecle T, Siqueira WL, Oppenheim FG, Hartshorn KL.

Oral Microbiol Immunol. 2009 Feb;24(1):18-24. doi: 10.1111/j.1399-302X.2008.00468.x.

11.

Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid.

White MR, Tecle T, Crouch EC, Hartshorn KL.

Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1293-9. Epub 2007 Aug 24.

12.

Minidefensins: antimicrobial peptides with activity against HIV-1.

Cole AM, Lehrer RI.

Curr Pharm Des. 2003;9(18):1463-73. Review.

PMID:
12769726
13.

θ-Defensins: cyclic peptides with endless potential.

Lehrer RI, Cole AM, Selsted ME.

J Biol Chem. 2012 Aug 3;287(32):27014-9. doi: 10.1074/jbc.R112.346098. Epub 2012 Jun 14.

14.
15.

Antiviral mechanisms of human defensins.

Wilson SS, Wiens ME, Smith JG.

J Mol Biol. 2013 Dec 13;425(24):4965-80. doi: 10.1016/j.jmb.2013.09.038. Epub 2013 Oct 2. Review.

16.

Antiviral activity of influenza virus M1 zinc finger peptides.

Nasser EH, Judd AK, Sanchez A, Anastasiou D, Bucher DJ.

J Virol. 1996 Dec;70(12):8639-44.

17.
18.

Antiviral activity of recombinant mouse β-defensin 3 against influenza A virus in vitro and in vivo.

Jiang Y, Yang D, Li W, Wang B, Jiang Z, Li M.

Antivir Chem Chemother. 2012 Aug 21;22(6):255-62. doi: 10.3851/IMP2077.

PMID:
22345365
19.

Retrocyclins and their activity against HIV-1.

Penberthy WT, Chari S, Cole AL, Cole AM.

Cell Mol Life Sci. 2011 Jul;68(13):2231-42. doi: 10.1007/s00018-011-0715-5. Epub 2011 May 7. Review.

20.

RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates.

Owen SM, Rudolph DL, Wang W, Cole AM, Waring AJ, Lal RB, Lehrer RI.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1157-65.

PMID:
15588337

Supplemental Content

Support Center